Synopsys - SNPS Stock Forecast, Price & News

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SNPS. Bank of America raised shares of Synopsys from an "underperform" rating to a "neutral" rating and lifted their price target for the stock from $325.00 to $360.00 in a research note on Wednesday, June 29th. Needham & Company LLC lifted their price target on shares of Synopsys from $370.00 to $380.00 and gave the stock a "buy" rating in a research note on Thursday, May 19th. Atlantic Securities dropped their price target on shares of Synopsys to $350.00 and set a "na" rating on the stock in a research note on Thursday, May 19th. Wells Fargo & Company dropped their price target on shares of Synopsys from $415.00 to $375.00 and set an "overweight" rating on the stock in a research note on Thursday, May 19th. Finally, StockNews.com downgraded shares of Synopsys from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, May 3rd. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $381.70.

Synopsys Stock Performance

NASDAQ:SNPS opened at $375.71 on Thursday. Synopsys has a one year low of $255.02 and a one year high of $381.70. The company has a 50-day simple moving average of $325.25 and a 200-day simple moving average of $310.55. The firm has a market capitalization of $57.47 billion, a PE ratio of 58.43, a price-to-earnings-growth ratio of 3.04 and a beta of 1.22.

Synopsys (NASDAQ:SNPS - Get Rating) last posted its quarterly earnings results on Wednesday, May 18th. The semiconductor company reported $1.89 EPS for the quarter, beating the consensus estimate of $1.80 by $0.09. Synopsys had a net margin of 21.19% and a return on equity of 18.23%. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.25 billion. During the same period in the previous year, the business posted $1.24 EPS. Equities analysts forecast that Synopsys will post 6.29 earnings per share for the current year.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider John F. Runkel, Jr. sold 3,463 shares of the business's stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $330.00, for a total transaction of $1,142,790.00. Following the sale, the insider now directly owns 22,623 shares in the company, valued at approximately $7,465,590. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Synopsys news, insider John F. Runkel, Jr. sold 3,463 shares of the business's stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $330.00, for a total transaction of $1,142,790.00. Following the sale, the insider now directly owns 22,623 shares in the company, valued at approximately $7,465,590. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Sassine Ghazi sold 4,651 shares of the business's stock in a transaction dated Friday, July 1st. The stock was sold at an average price of $300.67, for a total transaction of $1,398,416.17. Following the sale, the chief operating officer now owns 45,173 shares in the company, valued at $13,582,165.91. The disclosure for this sale can be found here. Insiders sold 129,285 shares of company stock valued at $39,219,908 in the last ninety days. Company insiders own 1.20% of the company's stock.